CA2070366C - Prophylactic/therapeutic composition for swine pleuropneumonia - Google Patents

Prophylactic/therapeutic composition for swine pleuropneumonia

Info

Publication number
CA2070366C
CA2070366C CA002070366A CA2070366A CA2070366C CA 2070366 C CA2070366 C CA 2070366C CA 002070366 A CA002070366 A CA 002070366A CA 2070366 A CA2070366 A CA 2070366A CA 2070366 C CA2070366 C CA 2070366C
Authority
CA
Canada
Prior art keywords
compound
bicozamycin
swine
pleuropneumonia
prophylactic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002070366A
Other languages
English (en)
French (fr)
Other versions
CA2070366A1 (en
Inventor
Masaaki Okada
Shigeyoshi Ura
Satoru Nakano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of CA2070366A1 publication Critical patent/CA2070366A1/en
Application granted granted Critical
Publication of CA2070366C publication Critical patent/CA2070366C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002070366A 1991-06-04 1992-06-03 Prophylactic/therapeutic composition for swine pleuropneumonia Expired - Fee Related CA2070366C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3-230722 1991-06-04
JP23072291 1991-06-04

Publications (2)

Publication Number Publication Date
CA2070366A1 CA2070366A1 (en) 1992-12-05
CA2070366C true CA2070366C (en) 1997-01-14

Family

ID=16912285

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002070366A Expired - Fee Related CA2070366C (en) 1991-06-04 1992-06-03 Prophylactic/therapeutic composition for swine pleuropneumonia

Country Status (9)

Country Link
US (1) US5264417A (enExample)
EP (1) EP0517394B1 (enExample)
JP (1) JPH0655671B2 (enExample)
AT (1) ATE124217T1 (enExample)
CA (1) CA2070366C (enExample)
DE (1) DE69203164T2 (enExample)
DK (1) DK0517394T3 (enExample)
ES (1) ES2073868T3 (enExample)
TW (1) TW197946B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994017073A1 (fr) * 1993-01-28 1994-08-04 Fujisawa Pharmaceutical Co., Ltd. Procede de production du benzoate de bicozamycine
US8519008B2 (en) 2003-01-22 2013-08-27 Purina Animal Nutrition Llc Method and composition for improving the health of young monogastric mammals
US8088782B2 (en) * 2008-05-13 2012-01-03 Astrazeneca Ab Crystalline 4-(3-chloro-2-fluoroanilino)-7 methoxy-6-{[1-(N-methylcarbamoylmethyl)piperidin-4-yl]oxy}quinazoline difumarate form A
MX2011006609A (es) * 2008-12-18 2011-06-30 Novartis Ag Sal de hemi-fumarato del acido 1-[4-[1-(4-ciclohexil-3-trifluoro-m etil-benciloxi-imino)-etil]-2-etil-bencil]-azetidin-3-carboxilico .

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4829158B1 (enExample) * 1970-10-12 1973-09-07
JPS5017996B2 (enExample) * 1971-10-01 1975-06-25
GB1568961A (en) * 1975-10-20 1980-06-11 Fujisawa Pharmaceutical Co Bicyclomycin derivatives
LU75516A1 (enExample) * 1976-08-02 1978-02-13
JPS5452731A (en) * 1977-09-14 1979-04-25 Fujisawa Pharmaceut Co Ltd Animal growth accelerator

Also Published As

Publication number Publication date
DK0517394T3 (da) 1995-08-28
JPH0655671B2 (ja) 1994-07-27
EP0517394A1 (en) 1992-12-09
CA2070366A1 (en) 1992-12-05
DE69203164T2 (de) 1995-11-02
JPH05148144A (ja) 1993-06-15
ATE124217T1 (de) 1995-07-15
EP0517394B1 (en) 1995-06-28
ES2073868T3 (es) 1995-08-16
TW197946B (enExample) 1993-01-11
DE69203164D1 (de) 1995-08-03
US5264417A (en) 1993-11-23

Similar Documents

Publication Publication Date Title
PT1420804E (pt) Métodos e composições para o controlo da coccidiose
CN116033923A (zh) Variovorax病菌作为球虫病替代治疗的用途
EP0681787B1 (en) Use of an enzyme for manufacturing an agent for the treatment and/or prophylaxis of coccidiosis
JP2003238400A (ja) 抗コクシジウム組成物及びそれを含有する飼料
EP1230922B9 (en) Agents for promoting fattening of animals and method of promoting fattening
CA2070366C (en) Prophylactic/therapeutic composition for swine pleuropneumonia
US4073884A (en) Promotion of feed efficiency
US4192887A (en) Ruminant coccidiostats
JP2535544B2 (ja) 抗生物質ＬＬ−Ｅ１９０２０αおよびβ
US4223040A (en) Lauric acid for the prevention and treatment of mycobacterial diseases
US4835185A (en) Immunomodulator for improving commercial performance of domestic animals
EP1389464A1 (en) Compositions containing bacterium capable of converting lactic acid into butyric acid and method of preventing/treating hyperlactic acidemia in digestive tract and colon cancer by using the same
EP0091649A1 (en) Method for increasing the efficiency of rumen fermentation of ruminant animals
US4794105A (en) Method for treatment of swine dysentery
US3943250A (en) Method and pharmaceutical preparations for treating and preventing physiological disturbances in vertebrates, caused by molds and yeasts
Little et al. The effect of vitamin C on performance of coccidia infected chickens fed omplete and vitamin deficient semi-purified diets
RU2415684C2 (ru) Фармацевтическая композиция для лечения и/или профилактики дисбиозов кишечника в процессе проведения антибактериальной терапии у теплокровных животных: крупного рогатого скота, свиней, домашних животных, в частности собак, кошек, и сельскохозяйственных птиц и способ лечения и/или профилактики дисбиозов кишечника в процессе проведения антибактериальной терапии у теплокровных животных: крупного рогатого скота, свиней, домашних животных, в частности собак, кошек, и сельскохозяйственных птиц
Wahlstrom et al. Growth effect of various antibiotics on baby pigs fed synthetic rations
JP2001518052A (ja) 長期治療のための獣医用経口フルオロキノロン抗菌組成物及び治療方法
KR102199186B1 (ko) 병원성 세균에 의한 질병의 예방 및 치료용 수의학적 조성물
EP3838347B1 (en) Evernimicin for treating diseases like necrotic enteritis
Overby et al. The Antithyrotoxic Factor of Liver: IV. Activity of Various Pure and Crude Materials
Yan et al. Macleaya cordata extract exhibits some potential as a surrogate antibiotic by improving gastrointestinal epithelial status and humoral response in goats
Hare Antibiotic potentiation—a review
USRE29244E (en) Coccidiostats

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed